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Abstract
Background—Acute otitis media (AOM) occurs as a complication of viral upper respiratory 
tract infections in young children. AOM and respiratory viruses both display seasonal variation. 
Our objective was to examine the temporal association between circulating respiratory viruses and 
the occurrence of pediatric ambulatory care visits for AOM.
Methods—This retrospective study included 9 seasons of respiratory viral activity (2002-2010) 
in Utah. We used Intermountain Healthcare's electronic medical records to assess community 
respiratory viral activity via laboratory-based active surveillance and to identify children <18 
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years with outpatient visits and ICD-9 codes for AOM. We assessed the strength of the association 
between AOM and individual respiratory viruses using interrupted time series analyses.
Results—During the study period, 96,418 respiratory viral tests were performed; 46,460 (48%) 
were positive. The most commonly identified viruses were: RSV (22%), rhinovirus (8%), 
influenza (8%), parainfluenza (4%), human metapneumovirus (3%), and adenovirus (3%). AOM 
was diagnosed during 271,268 ambulatory visits. There were significant associations between 
peak activity of RSV, human metapneumovirus, influenza A, and office visits for AOM. 
Adenovirus, parainfluenza, and rhinovirus were not associated with visits for AOM.
Conclusions—Seasonal RSV, human metapneumovirus, and influenza activity were temporally 
associated with increased diagnoses of AOM among children. These findings support the role of 
individual respiratory viruses in the development AOM. These data also underscore the potential 
for respiratory viral vaccines to reduce the burden of AOM.
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Background
Acute upper respiratory tract infections are one of the most common reasons for medical 
encounters and hospitalizations during childhood.1,2 More than 60% of upper respiratory 
tract infection episodes are complicated by acute otitis media (AOM); a common reason for 
outpatient healthcare visits and antibiotic prescribing in children.3 Previous studies using 
culture techniques reported isolation of respiratory viruses among children with AOM and 
demonstrated a significantly higher risk for development of AOM following infection by 
respiratory syncytial virus (RSV) and influenza virus.4-6 Molecular diagnostic methods have 
enhanced our ability to detect established and emerging pathogens (e.g. human 
metapneumovirus) responsible for respiratory tract infections and have further established 
the importance of respiratory viruses in pediatric respiratory infections and AOM.7,8
Understanding the role of respiratory viruses and the development of AOM is challenging, 
as individual viruses may differ in middle ear tropism and in their ability to cause viral or 
bacterial middle ear infections.9 However, improved understanding of which respiratory 
viruses are most closely associated with the development of AOM may be useful in the 
clinical evaluation of children with upper respiratory tract infections and in the development 
of viral vaccines for AOM prevention. Our objective was to examine the strength of the 
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Setting and Study Population
We performed a retrospective study of respiratory viral activity from January 2002 through 
December 2010 (9 years) in Utah using the Intermountain system. Intermountain is a large 
vertically-integrated non-profit healthcare system that owns and operates 22 hospitals and 
more than 100 ambulatory care clinics in Utah and southern Idaho, including Primary 
Children's Medical Center (PCMC), a tertiary Children's hospital in Salt Lake City, UT.
We evaluated associations between respiratory viral activity among children younger than 
18 years and ambulatory care visits for AOM, as defined below. We analyzed cases of AOM 
for all Utah-resident children who received care at an Intermountain facility. Although 
marketshare data for outpatient visits were not available, approximately 75-85% of all 
pediatric hospitalizations for Utah residents occurred at Intermountain facilities and this 
proportion remained stable throughout the study period (courtesy of Jim Bradshaw, Director 
of Strategic Planning, Intermountain Healthcare, Salt Lake City, UT).
Respiratory Viral Testing
Testing for adenovirus, influenza A and B viruses, parainfluenza viruses 1, 2, and 3, and 
RSV has been performed using direct fluorescent antibody (DFA), enzyme immunoassay 
(EIA), and viral culture in the Intermountain system since 2001. Testing for human 
metapneumovirus by DFA and rhinovirus by PCR began in 2006 and 2007, respectively. 
From 2002 through 2008, DFA-negative specimens were submitted for viral culture. 
Beginning in 2009, DFA-negative samples were submitted for multiplex PCR testing 
(Luminex xTAG Respiratory Virus Panel; Luminex Diagnostics, Austin, Texas). This PCR-
based assay detects adenovirus, influenza A and B, parainfluenza 1-3, RSV, human 
metapneumovirus, and rhinovirus. Respiratory samples (e.g., nasopharyngeal aspirates) were 
obtained primarily from children with respiratory symptoms in emergency department and 
inpatient settings. Respiratory specimens were tested for the purposes of isolation, 
cohorting, and medical treatment. In addition, at PCMC respiratory viral testing was 
recommended for all febrile infants younger than 90 days of age from 2005 and for all 
Intermountain facilities from 2008.
Identification of Acute Otitis Media
In 2004, the American Academy of Pediatrics (AAP) published a clinical practice guideline 
defining the diagnosis of AOM as signs of middle-ear effusion, signs and symptoms of 
middle-ear inflammation, and confirmation of acute onset.10 For this study, AOM was 
defined based on billing codes using International Classification of Diseases, Ninth Revision 
(ICD-9) codes. All Intermountain facilities share an electronic records system that includes 
demographic, clinical, microbiologic, and financial data. We queried the system for cases of 
AOM among Utah children younger than 18 years at all Intermountain facilities over 9 
years. AOM-specific ICD-9 codes included 381 (acute non-suppurative, serous, mucoid, and 
sanguinous otitis media) and 382 (acute suppurative otitis media with and without 
spontaneous rupture of the eardrum), as previously described by Zhou et al.11
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We calculated the absolute number of ICD-9 coded AOM episodes and the frequency of 
individual respiratory viruses identified in Utah throughout the Intermountain system. These 
data were tabulated in 1-week increments for statistical analyses. We calculated the 
proportion of positive tests by dividing the number of individual viruses identified each 
week by the number of viral tests performed.
Correlations between each respiratory virus and AOM were explored by Spearman rank 
correlations. With the goal of controlling for the auto-correlation of time series data, we 
used methods developed by Box and Jenkins to build an autoregressive integrated moving 
average (ARIMA) time series model.12 To account for the seasonal and periodical patterns 
of AOM and individual respiratory viruses, we modeled the difference – or change – from 
one week to the next, rather than modeling the series itself. The final model also compared 
the lag time between the detection of respiratory viruses and the date of ICD-9 coded AOM 
diagnosis at 0, 2, 4, and 8 weeks. Statistical analyses were performed using SAS software 
9.1.3 (SAS Institute, Cary, NC) and Stata11.2 (StataCorp LP, College Station, TX, USA).
Results
Identification of Viral Respiratory Tract Infections
From January 2002 through December 2010, 46,460 (48%) of 96,418 unique respiratory 
samples submitted for viral testing were positive (Table 1). The respiratory viruses detected 
showed winter seasonality (Fig., Supplemental Digital Content 1, http://links.lww.com/INF/
B415).
Seasonality of Viral Respiratory Tract Infections
The seasonal patterns of circulating respiratory viruses are shown in Figure 1 and Figure, 
Supplemental Digital Content 2, http://links.lww.com/INF/B416. RSV, influenza, and 
human metapneumovirus showed distinctive and variable winter peaks. Ninety-eight percent 
of positive RSV and 93% of positive human metapneumovirus detections occurred between 
November and April. The seasonality was somewhat different for influenza, with only 56% 
of detections occurring between these months. This was due to two waves of the 2009 H1N1 
pandemic in May and September of 2009. With the exception of the 2003-2004 and 
2009-2010 seasons, peak RSV, influenza, and human metapneumovirus activity overlapped 
to variable degrees. The seasonality of adenovirus, rhinovirus, and parainfluenza was less 
pronounced (Figure, Supplemental Digital Content 2, http://links.lww.com/INF/B416).
Seasonality of ICD-9 Coded Acute Otitis Media
During the study period 271,268 children residing in Utah were diagnosed with AOM at an 
Intermountain facility. There was an average of 30,141 AOM diagnoses per year, with the 
largest number (34,934) occurring during the 2003-2004 season. AOM diagnoses exhibited 
moderate seasonality, with 66% of visits identified between November and April of each 
year. The majority of AOM visits (77%) were among children younger than 5 years of age.
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Correlations between Acute Otitis Media and Circulating Respiratory Viruses
There were strong correlations observed between AOM visits at Intermountain facilities and 
the activity of individual circulating respiratory viruses. AOM visits were strongly 
correlated with the isolation of RSV (r=0.87; P<0.001) and human metapneumovirus 
(r=0.79, P<0.001). We found statistically significant but weaker correlations between AOM 
and influenza A (r=0.53; P<0.001), influenza B (r=0.43; P<0.001), adenovirus (r=0.40; 
P<0.001), and rhinovirus (r=0.38; P<0.001). The correlation with AOM at time lags of 2, 4, 
and 8 weeks although weaker, remained significant. When first-order auto-regressive 
integrated moving average (ARIMA) models were constructed that appropriately corrected 
for the autocorrelation of our time-series data, the association was no longer statistically 
significant for a number of respiratory viruses (Table 2). However, RSV and human 
metapneumovirus both remained significantly associated with AOM at 2 weeks (P<0.001) 
and 4 weeks (P<0.001), and the strongest association was observed at lag times of 8 weeks 
(P<0.001) and 7 weeks (P<0.001), respectively. The strength and timing of these 
associations were similar among children <5 years and those 5-17 years of age.
A weaker association was found with influenza A, which varied by age. Among children 
younger than 5 years, the association between influenza A and AOM was strongest without 
a lag (P=0.04). However, among children 5-17 years of age the strongest associations were 
found at 3 weeks (P=0.02) and 4 weeks (P=0.009). A weak association was also observed 
for influenza B at 8 weeks (P=0.04). Adenovirus, parainfluenza, and rhinovirus were not 
associated with AOM visits when modeled at time 0 or with lag times up to 8 weeks.
Discussion
Respiratory viral infections have long-been implicated in the pathogenesis of AOM. 
However, the contribution and influence of specific respiratory viruses to the development 
of AOM is not well understood. In this population-based ecologic study, we demonstrated 
temporal associations between RSV, human metapneumovirus, and influenza activity in a 
large healthcare system with AOM, as measured by ICD-9 coding of AOM clinic 
discharges. In contrast, we did not observe an association between adenovirus, 
parainfluenza, or rhinovirus activity and health care visits for AOM.
AOM is the most common cause of health care visits among children in the United States. 
More than 70% of children have experienced at least one episode of AOM by 2 years of 
age.13 In the United States, direct and indirect medical expenditures for AOM-related 
healthcare visits and antibiotic prescriptions are estimated to be $3.5 billion in this age 
group.11,14 AOM is often regarded as a bacterial infection and is the primary indication for 
more than 10 million antibiotic prescriptions annually among children younger than 18 
years.2 Bacteria have been identified in 50-90% of middle ear fluid samples from children 
with AOM.15,16 However, newer molecular detection methods have increased the detection 
of respiratory viruses—alone and in combination with bacteria in the middle ear fluid of 
children with AOM.17 Ruohola et al18 evaluated the etiology of AOM among children with 
tympanostomy tubes and identified viruses in 70% of cases. Moreover, they detected viral 
and bacterial co-infections in 66% of children with AOM.
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The risk of developing AOM following a viral upper respiratory tract infection appears to 
vary by virus, but assessing the contribution of individual respiratory viruses has been 
difficult, primarily due to differences in methodologies. Ruusaken et al6, using respiratory 
viral antigen testing of nasopharyngeal specimens, noted a significant correlation between 
AOM and RSV. In this study, AOM developed in 57% of children with RSV infection, 
compared with 35% with influenza A infection, with lower rates for other respiratory 
viruses. In another study, Henderson et al4, testing nasopharyngeal specimens by viral 
culture, reported a strong association between RSV, influenza A and B, adenovirus and 
parainfluenza with AOM, with AOM developing in 33% of RSV positive children. 
Moreover, they found that rhinovirus outbreaks either preceded or coincided with peaks in 
AOM diagnoses.
In our study, using a combination of antigen detection, viral culture, and PCR for respiratory 
viral detection, we found results that are similar in several ways to previous studies.4,6 We 
observed a strong temporal association between AOM and RSV activity. In addition, the 
effects of RSV were also prolonged with a lag period extending past 8 weeks. We also noted 
a significant association between AOM and influenza virus, similar to previous studies.4-6 In 
our dataset, the effect of influenza on AOM varied by age. There was no lag between 
influenza A activity and AOM among young children (<5 years), but the association began 
at 4 weeks in older children (≥ 5 years old). We do not believe that this lag reflects the risk 
of developing AOM among individuals; rather, it may reflect the epidemiologic impact of 
respiratory viruses at the population level. The reason for this differential effect of influenza 
on AOM is unknown, and needs further investigation.
Our study is one of the first to demonstrate a strong and prolonged association between 
AOM and human metapneumovirus, with the best fit achieved using lag periods from 4 
weeks to more than 8 weeks. The strength of this association was comparable to that of 
RSV. The role of human metapneumovirus in AOM has not been well defined. Boivin et 
al19 reported that approximately 50% of patients admitted for human metapneumovirus 
infection displayed “otitis” symptoms. Using PCR, Williams et al20 evaluated viral culture-
negative nasal wash and middle ear fluid specimens from children with AOM and detected 
human metapneumovirus in 6% of nasal wash samples. In another study by Nokso-Koivisto 
et al21, AOM developed in 24% of children with confirmed human metapneumovirus upper 
respiratory tract infection. Our finding of a strong temporal association between human 
metapneumovirus and AOM supports the role of human metapneumovirus in the etiology of 
AOM.
Contrary to earlier reports, we did not observe an association between AOM and rhinovirus, 
adenovirus, or parainfluenza activity.3,6,17 This may be the result of our use of ARIMA 
models, which assess changes in activity compared to the previous week rather than the 
absolute number of cases. This method is powerful as it does not disregard the stochastic 
dependence of consecutive measurements. For example, a high burden of respiratory viral 
activity today tends to predict high activity the next day (positive auto-correlation). ARIMA 
models are useful for discriminating between natural seasonal patterns and true 
associations.22 However, the transformation of data to a stationary series through 
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differencing has the potential to underestimate a true association with viruses which display 
milder seasonal fluctuations, such as rhinovirus.23
Although temporal association does not prove a causal relationship, many lines of evidence 
suggest a direct role for respiratory viruses in the pathogenesis of AOM. Animal studies 
have demonstrated synergism between respiratory viral infections and AOM in chinchillas 
following intranasal inoculation with influenza A virus, S. pneumoniae, or both pathogens.24 
In humans, many studies have demonstrated the presence of respiratory viruses in the MEF 
of children with AOM by antigen detection, culture, or nucleic acid detection. Furthermore 
the testing of MEF and nasopharyngeal specimens by PCR has detected viruses that were 
infrequently detected by other methods.25 As a result, rhinovirus, other picornaviruses, 
human metapneumovirus, and coronavirus have increasingly been detected from MEF and 
nasopharyngeal specimens of children with AOM.3,21 However, prolonged nasopharyngeal 
shedding of rhinovirus, enterovirus, bocavirus, and adenovirus26-28 in both symptomatic29 
and asymptomatic30 children limits the ability to determine the significance of the detection 
of these viruses in AOM. This may explain, in part, the absence of an epidemiologic 
correlation between rhinovirus, adenovirus and parainfluenza and AOM in this study.
Several studies have shown clear benefits of influenza vaccines in preventing AOM, with 
reductions of AOM of 30% to 83% among vaccine recipients.31-33 Utah influenza 
immunization coverage was 49.2% (±7.3%) in 2010-2011 among children 6 months to 17 
years of age, according to the Centers for Disease Control and Prevention's (CDC) National 
Immunization Survey.34 These data suggest that more effective immunization strategies 
have the potential to decrease the burden of influenza-associated AOM. In a study on the 
prevention of RSV infection by passive immune prophylaxis, intravenous RSV-immune 
globulin administered to premature infants decreased the incidence of AOM by 80%.35 
Passive antibody therapy is too expensive to have a major impact on the burden of AOM, 
but vaccines for RSV are under development.36 Moreover, preliminary studies of the 
antigenic epitopes of human metapneumovirus may lead to the development of human 
metapneumovirus vaccines.37
This study is subject to several limitations. First, this study was not designed to demonstrate 
a causal relationship between individual respiratory viruses and the development of AOM. 
Therefore, the temporal associations we observed must be further investigated by clinical 
studies at the patient level. It is unclear why the lag time between respiratory viral activity 
and AOM diagnoses differed by age group. Second, it is possible that viral testing may have 
been more likely to be ordered for subjects who complained of earaches, as opposed to those 
who reported generalized viral symptoms. Third, because respiratory viral testing was 
primarily performed among inpatients and those presenting to emergency departments our 
findings may not reflect the association between respiratory viruses, including rhinoviruses, 
and AOM in the outpatient setting. Fourth, we could not assess the immunization status of 
the children included in this study. Vaccine coverage for influenza and pneumococcal 
conjugate vaccines rose throughout the study period and were comparable to national rates. 
The rates measured by the CDC's 2011 National Immunization (influenza 49.2% and 
pneumococcal conjugate vaccine 80.1%) were comparable to national rates.34,38 Fifth, we 
could not account for environmental factors such as pollution, humidity, temperature, and 
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rainfall, which may represent potential confounding factors.39 Sixth, newly described 
respiratory viruses including non-SARS coronaviruses and bocavirus were not evaluated. 
Seventh, our study was based in a single geographic region and thus our findings may not be 
generalizable. Lastly, the use of ICD-9 discharge codes may lead to misclassification, 
potentially incorrectly ascribing cases of AOM. We were unable to independently assess the 
presence of the AAP's diagnostic criteria among our cohort of patients;10 however, ICD-9 
coded AOM has been reported to be in 94% agreement with manual review of the medical 
record.40
AOM is the most common bacterial infection and the most frequent indication for antibiotic 
therapy in young children, with substantial clinical and economic impact. Therefore, efforts 
to prevent AOM are desperately needed. Our study provides evidence of strong temporal 
relationships between AOM visits among children and RSV, human metapneumovirus, and 
influenza activity. We speculate that a meaningful reduction in the overall incidence of 
AOM could be accomplished by the effective control of RSV, human metapneumovirus, and 
influenza.
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Weekly relationship between ICD-9 coded acute otitis media (AOM) and human 
metapneumovirus, influenza A, and respiratory syncytial virus (RSV) by age group: A) 
children 0-4 years and B) children 5-17 years of age.
Note: The dual influenza A peaks in 2009 correspond to the Spring and Fall waves of the 
2009 H1N1 pandemic.
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Table 1
Frequency of respiratory viral detection by testing period.
Respiratory Virus Jan 2002 – Nov 2006 Dec 2006 – Oct 2007 Nov 2007 – Dec 2010 Total
RSV 9579 (26%) 1934 (21%) 9815 (19%) 21328 (22%)
Influenza A 1344 (4%) 340 (4%) 5261 (10%) 6945 (7%)
Influenza B 339 (1%) 120 (1%) 448 (1%) 907 (1%)
Parainfluenza 1709 (5%) 435 (5%) 1893 (4%) 4037 (4%)
Adenovirus 999 (3%) 309 (3%) 1603 (3%) 2911 (3%)
Human metapneumovirus* -- 436 (5%) 2385 (5%) 2821 (3%)
Rhinovirus** -- -- 7511 (15%) 7511 (8%)
Negative 22646 (62%) 5537 (62%) 21775 (43%) 49958 (52%)
*
Human metapneumovirus testing began in November 2006.
**
Rhinovirus testing began in November 2007.
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Table 2
Autoregressive integrated moving average (ARIMA) analysis for circulating respiratory viruses and acute 
otitis media.
Respiratory Virus Lag Time < 5 years (P-value) 5 – 17 years (P-value)
Influenza A
No lag 0.04 0.10
1-week lag 0.20 0.75
2-week lag 0.94 0.30
4-week lag 0.43 0.01
8-week lag 0.46 0.36
Influenza B
No lag 0.33 0.69
1-week lag 0.34 0.43
2-week lag 0.99 0.24
4-week lag 0.37 0.81
8-week lag 0.04 0.10
RSV
No lag 0.65 0.27
1-week lag 0.18 0.91
2-week lag 0.01 0.28
4-week lag <0.01 <0.01
8-week lag <0.01 <0.01
Human metapneumovirus
No lag 0.41 0.92
1-week lag 0.27 0.38
2-week lag 0.07 0.17
4-week lag <0.01 <0.01
8-week lag <0.01 <0.01
Adenovirus
No lag 0.48 0.39
1-week lag 0.16 0.66
2-week lag 0.65 0.88
4-week lag 0.32 0.51
8-week lag 0.13 0.30
Parainfluenza
No lag 0.50 0.69
1-week lag 0.47 0.83
2-week lag 0.59 0.99
4-week lag 0.37 0.24
8-week lag 0.34 0.58
Rhinovirus
No lag 0.84 0.78
1-week lag 0.86 0.83
2-week lag 0.56 0.66
4-week lag 0.29 0.68
8-week lag 0.30 0.41
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